Activation of NK Cells in Mixed Cultures of Wharton’s Jelly Mesenchymal Stromal Cells and Peripheral Blood Lymphocytes


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Mesenchymal stromal cells possess immunosuppressive properties that might be used for the therapy of inflammatory diseases of various geneses. The effects of mesenchymal stromal cells depend on their lifetime in the recipient tissues. During heterologous transplantation, mesenchymal stromal cells are eliminated by NK cells. We studied NK cell formation in mixed cultures of Wharton’s jelly mesenchymal stromal cells and peripheral blood lymphocytes from an autologous donor. Lymphocytes were activated by a mitogen or IL-2. The lifetime of mesenchymal stromal cells was estimated by MTT test. Cytotoxic activity and phenotype of NK cells were evaluated by flow cytometry. It was found that activation of NK cells depended on IL-2 and was registered on day 2 of incubation with IL-2. In cultures with mitogen-activated lymphocytes, cytotoxicity was observed after 5-6 days. Cytotoxicity of NK correlated with significant decrease in CD16+ and increase in CD56+ NK and with reduction of mesenchymal stromal cell viability. Thus, the main mechanism of elimination of mesenchymal stromal cells is cytotoxicity of NK cells that depended on IL-2 production.

About the authors

E. V. Svirshchevskaya

M. M. Shemyakin and Yu. A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Author for correspondence.
Email: esvir@mx.ibch.ru
Russian Federation, Moscow

A. M. Poltavtsev

Institute of Applied Mechanics, Russian Academy of Sciences

Email: esvir@mx.ibch.ru
Russian Federation, Moscow

G. Zh. Os’mak

V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of the Health of the Russian Federation

Email: esvir@mx.ibch.ru
Russian Federation, Moscow

R. A. Poltavtseva

V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of the Health of the Russian Federation

Email: esvir@mx.ibch.ru
Russian Federation, Moscow


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies